Mednet Logo
HomePrimary CareQuestion

How would you treat active rheumatoid arthritis in a patient in complete response on loralatinib for stage IV ALK positive NSCLC?

1 Answers
Mednet Member
Mednet Member
Rheumatology · Ohio State University

I would do my best to minimize immunosuppression. I would use IL-6 or Abatacept and possibly rituximab. Have done all to minimize DMARDs and have had success with all 3.

Register or Sign In to see full answer